Law & Policy

·

Policy

Congressional Caucus Seeks Public Input on Psychedelic Therapy

Congressional Caucus Seeks Public Input on Psychedelic Therapy

What they found

The bipartisan PATH Caucus sought public input by Nov. 5 to shape regulations for therapeutic psychedelics.

The bipartisan PATH Caucus sought public input by Nov. 5 to shape regulations for therapeutic psychedelics.

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Published in

Marijuana Moment

Marijuana Moment

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

Tell Them More

Tell Them More

Bipartisan lawmakers Reps. Jack Bergman (R-MI) and Lou Correa (D-CA) seek public input by Nov. 5 to help shape regulations for therapeutic use of psychedelics. The Congressional Psychedelics Advancing Therapies (PATH) Caucus is especially interested in feedback from those experienced with psychedelics-assisted therapy, stakeholders in mental health, and indigenous communities.

Bipartisan lawmakers Reps. Jack Bergman (R-MI) and Lou Correa (D-CA) seek public input by Nov. 5 to help shape regulations for therapeutic use of psychedelics. The Congressional Psychedelics Advancing Therapies (PATH) Caucus is especially interested in feedback from those experienced with psychedelics-assisted therapy, stakeholders in mental health, and indigenous communities.

Psilocybin vs. Lexapro, Benefits of Truffles, and Mycelium Shoes

Read the original study ↗

Get Shroom Scan

Next study

Psilocybin Therapy Offers Hope for Veterans With PTSD ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →